chnology and services to
evaluate cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the clinical
trials process by enabling its customers to automate the collection,
analysis, and distribution of clinical data in all phases of clinical
development.
Statements included in this release may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform
Act of 1995. Such statements, including but not limited to 2008 financial
guidance, involve a number of risks and uncertainties such as the company's
ability to obtain new contracts and accurately estimate net revenues due to
uncertain regulatory guidance, variability in size, scope and duration of
projects, and internal issues at the sponsoring client, integration of
acquisitions, competitive factors, technological development, and market
demand. As a result, actual results may differ materially from any
financial outlooks stated herein. Further information on potential factors
that could affect the company's financial results can be found in the
company's Reports on Form 10-K and 10-Q filed with the Securities and
Exchange Commission. The company undertakes no obligation to publicly
update any forward-looking statement, whether as a result of new
information, future events or otherwise.
'/>"/>SOURCE eResearchTechnology, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 20082.
eResearchTechnology, Inc. to Present at the Thomas Weisel Healthcare Conference on September 4th, 20083.
eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 20084.
eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services5.
eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 20086.
China Yingxia International, Inc. Announces $2 Million Share Repurchase Program7.
Pathwork Diagnostics Announces Key Additions to Management Team8.
The Michigan Life Sciences Pipeline Announces The Funding Place(TM) and Other Resources to Connect Investors and Startups9.
Radi Medical Systems Announces Schedule for TCT 200810.
EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity11.
BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board